Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Poncelet

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Psychopharmacology|July 1, 1997
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptorsM Arnone, J Maruani, F Chaperon, et al.
Revue Neurologique|January 1, 1989
[Neurologic forms of Lyme disease. 12 cases]F Viader, A M Poncelet, F Chapon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
Neuropharmacological profile of non-peptide neurotensin antagonistsD Gully, F Jeanjean, M Poncelet, et al.
Journal of Immunoassay|January 1, 1990
Immunoassay of theophylline by latex particle countingS M Poncelet, J N Limet, J P Noel, et al.
The New Phytologist|April 20, 2021
Genetic structure and mating systems of metallicolous and nonmetallicolous populations of Thlaspi caerulescensS Dubois, P-O Cheptou, C Petit, et al.
Neuroimage|May 17, 2006
The left intraparietal sulcus and verbal short-term memory: focus of attention or serial order?S Majerus, M Poncelet, M Van der Linden, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1993
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptorD Gully, M Canton, R Boigegrain, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1993
Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonistM Poncelet, M Arnone, M Heaulme, et al.
Neuropharmacology|June 1, 1993
Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742AM Poncelet, V Santucci, R Paul, et al.
Regulatory Peptides|July 2, 1993
SR 48968, a neurokinin A (NK2) receptor antagonistX Emonds-Alt, C Advenier, T Croci, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Psychopharmacology|July 1, 1997
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptorsM Arnone, J Maruani, F Chaperon, et al.
Revue Neurologique|January 1, 1989
[Neurologic forms of Lyme disease. 12 cases]F Viader, A M Poncelet, F Chapon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
Neuropharmacological profile of non-peptide neurotensin antagonistsD Gully, F Jeanjean, M Poncelet, et al.
Journal of Immunoassay|January 1, 1990
Immunoassay of theophylline by latex particle countingS M Poncelet, J N Limet, J P Noel, et al.
The New Phytologist|April 20, 2021
Genetic structure and mating systems of metallicolous and nonmetallicolous populations of Thlaspi caerulescensS Dubois, P-O Cheptou, C Petit, et al.
Neuroimage|May 17, 2006
The left intraparietal sulcus and verbal short-term memory: focus of attention or serial order?S Majerus, M Poncelet, M Van der Linden, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1993
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptorD Gully, M Canton, R Boigegrain, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1993
Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonistM Poncelet, M Arnone, M Heaulme, et al.
Neuropharmacology|June 1, 1993
Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742AM Poncelet, V Santucci, R Paul, et al.
Regulatory Peptides|July 2, 1993
SR 48968, a neurokinin A (NK2) receptor antagonistX Emonds-Alt, C Advenier, T Croci, et al.
Pageof 6